Back to top

messenger-rna: Archive

Zacks Equity Research

Moderna's (MRNA) Omicron BA.4/5 Booster Jab Study Meets Goal

Moderna's (MRNA) Omicron-targeting bivalent COVID vaccines exhibit substantial antibody response compared with an original booster dose of Spikevax.

PFENegative Net Change VRTXNegative Net Change MRNAPositive Net Change BNTXNegative Net Change

Zacks Equity Research

Sanofi (SNY), GSK Receive EU Approval for COVID-19 Vaccine

Sanofi (SNY) and partner GSK's COVID-19 vaccine receives authorization in the European Union for use as a booster in adults aged 18 years and older.

SNYPositive Net Change GSKNegative Net Change PFENegative Net Change BNTXNegative Net Change